Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis

References

• Ahad A, Raish M, Ahmad A, et al. (2018). Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats. Eur J Pharm Sci 111:409–17.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Singhal M, Amin S, et al. (2017). Bile salt stabilized vesicles (bilosomes): a novel nano-pharmaceutical design for oral delivery of proteins and peptides. Curr Pharm Des 23:1575–88.
   PubMed Web of Science ®Google Scholar
• Alphandery E. (2019). Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease. Nanotoxicology 13:573–96.
   PubMed Web of Science ®Google Scholar
• Bnyan R, Khan I, Ehtezazi T, et al. (2018). Surfactant effects on lipid-based vesicles properties. J Pharm Sci 107:1237–46.
   PubMed Web of Science ®Google Scholar
• Chen KH, Lundy DJ, Toh EK, et al. (2015). Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific. Nanoscale 7:15863–72.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Q-w, Zuo J, et al. (2017). Anti-arthritic activity of ethanol extract of Claoxylon indicum on Freund’s complete adjuvant-induced arthritis in mice. BMC Complement Altern Med 17:11.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yuan L, Zhou L, et al. (2012). Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine. Int J Nanomedicine 7:4581–91.
   PubMed Web of Science ®Google Scholar
• D'Elia RV, Woods S, Butcher W, et al. (2019). Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments. J Control Release 298:202–12.
   PubMed Web of Science ®Google Scholar
• Deng W, Wang H, Wu B, et al. (2019). Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect. Acta Pharm Sin B 9:74–86.
   PubMed Web of Science ®Google Scholar
• Deng W, Xie Q, Wang H, et al. (2017). Selenium nanoparticles as versatile carriers for oral delivery of insulin: insight into the synergic antidiabetic effect and mechanism. Nanomedicine 13:1965–74.
   PubMed Web of Science ®Google Scholar
• Fernandez-Zafra T, Gao T, Jurczak A, et al. (2019). Exploring the transcriptome of resident spinal microglia after collagen antibody-induced arthritis. Pain 160:224–36.
   PubMed Web of Science ®Google Scholar
• Freag MS, Saleh WM, Abdallah OY. (2018). Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol. Int J Pharm 535:18–26.
   PubMed Web of Science ®Google Scholar
• Guo L, Luo S, Du Z, et al. (2017). Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis. Nat Commun 8:878.
   PubMed Web of Science ®Google Scholar
• Hussain A, Singh S, Sharma D, et al. (2017). Elastic liposomes as novel carriers: recent advances in drug delivery. Int J Nanomedicine 12:5087–108.
   PubMed Web of Science ®Google Scholar
• Jain S, Patel N, Shah MK, et al. (2017). Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci 106:423–45.
   PubMed Web of Science ®Google Scholar
• Jia Z, He J. (2016). Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2. Exp Ther Med 11:655–9.
   PubMed Web of Science ®Google Scholar
• Kosovrasti VY, Nechev LV, Amiji MM. (2016). Peritoneal macrophage-specific TNF-α gene silencing in LPS-induced acute inflammation model using CD44 Targeting Hyaluronic Acid Nanoparticles. Mol Pharm 13:3404–16.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang T, Ye Y, et al. (2015). Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material. Int J Pharm 495:948–55.
   PubMed Web of Science ®Google Scholar
• Litwiniuk M, Krejner A, Speyrer MS, et al. (2016). Hyaluronic acid in inflammation and tissue regeneration. Wounds 28:78–88.
   PubMed Web of Science ®Google Scholar
• Misra S, Hascall VC, Markwald RR, et al. (2015). Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol 6:201.
   PubMed Web of Science ®Google Scholar
• Ng SW, Chan Y, Chellappan DK, et al. (2019). Molecular modulators of celastrol as the keystones for its diverse pharmacological activities. Biomed Pharmacother 109:1785–92.
   PubMed Web of Science ®Google Scholar
• Palvai S, Kuman MM, Sengupta P, et al. (2017). Hyaluronic acid layered chimeric nanoparticles: targeting MAPK-PI3K signaling hub in colon cancer cells. ACS Omega 2:7868–80.
   PubMed Web of Science ®Google Scholar
• Pandey S, Mahtab A, Rai N, et al. (2017). Emerging role of CD44 receptor as a potential target in disease diagnosis: a patent review. Recent Pat Inflamm Allergy Drug Discov 11:77–91.
   PubMed Web of Science ®Google Scholar
• Qi X, Qin J, Ma N, et al. (2014). Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation. Int J Pharm 472:40–7.
   PubMed Web of Science ®Google Scholar
• Sanna V, Chamcheu JC, Pala N, et al. (2015). Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment. Int J Nanomedicine 10:6835–46.
   PubMed Web of Science ®Google Scholar
• Shukla A, Mishra V, Kesharwani P. (2016). Bilosomes in the context of oral immunization: development, challenges and opportunities. Drug Discov Today 21:888–99.
   PubMed Web of Science ®Google Scholar
• Siu FY, Ye S, Lin H, et al. (2018). Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. Int J Nanomedicine 13:4133–44.
   PubMed Web of Science ®Google Scholar
• Soe ZC, Thapa RK, Ou W, et al. (2018). Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Colloids Surf B Biointerfaces 170:718–28.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li X, Zhang L, et al. (2019). Cell permeable NBD peptide-modified liposomes by hyaluronic acid coating for the synergistic targeted therapy of metastatic inflammatory breast cancer. Mol Pharm 16:1140–55.
   PubMed Web of Science ®Google Scholar
• Yadav P, Jaswal V, Sharma A, et al. (2018). Celastrol as a pentacyclic triterpenoid with chemopreventive properties. Pharm Pat Anal 7:155–67.
   PubMed Web of Science ®Google Scholar
• Yin J, Wang P, Yin Y, et al. (2017). Optimization on biodistribution and antitumor activity of tripterine using polymeric nanoparticles through RES saturation. Drug Deliv 24:1891–7.
   PubMed Web of Science ®Google Scholar
• Yu C, Li X, Hou Y, et al. (2019). Hyaluronic acid coated acid-sensitive nanoparticles for targeted therapy of adjuvant-induced arthritis in rats. Molecules 24:146.
   Web of Science ®Google Scholar
• Zhang X, Zhang T, Ye Y, et al. (2015). Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect. Eur J Pharm Biopharm 94:30–41.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang T, Zhou X, et al. (2014). Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation. J Pharm Sci 103:1711–9.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tan Y, Meng T, et al. (2018). Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using celastrol-loaded micelles. Drug Deliv 25:341–52.
   PubMed Web of Science ®Google Scholar